Animal Production articles for Regeneron Pharmaceuticals, United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

Article ‘Count’ for Animal Production.

Topic

Journal

Count

Nature Communications

0.95

Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity 2026-03-13

0.95

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.

Latest supplements

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Access free

Nature Index 2026 Nanoscience and nanotechnology

From programmable RNA architectures to next-generation materials for energy and healthcare, researchers are harnessing the unusual properties of the nanoscale to tackle some of society's biggest challenges. This supplement explores the discoveries that are driving the field, the hurdles that remain and the institutions that are leading in nanoscience and nanotechnology research.

Access free

Research Leaders survey

Insights from 6,000+ top-tier researchers on funding pressures, research impact, mobility and emerging technologies shaping the future of global research.

Access the Research Leaders report

Nature Strategy Reports

Comprehensive deep-dives and custom high-quality reports into relevant research topics to influence major research and funding decisions.

Learn more